AQUACULTURE

Oral shrimp vaccine gets market launch funding

Biotech company, ViAqua Therapeutics, has completed a US$8.25 million funding round to help market its orally-administered vaccine for shrimp.

shrimp

Biotech company, ViAqua Therapeutics, has completed a US$8.25 million funding round to help market its orally-administered vaccine for shrimp.

Related Articles

Pieter van West AQUACULTURE

SAIC strengthens science panel with appointments

Gloria Maris seabream and seabass farm AQUACULTURE

French seabass farm earns ASC certification

oysters on a bed of ice AQUACULTURE

Satellite data helps Maine oyster farms